Clinical Trial Update: A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor

View source ↗

Summary

An observational Norwegian trial evaluating treatment with Afinitor (everolimus) in patients with metastatic renal cell carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Renal Cell Carcinoma (mRCC) | Status: COMPLETED